Show simple item record

dc.contributor.authorEzeala, C.C.
dc.contributor.authorChukwurah, E.
dc.date.accessioned2015-12-18T12:13:27Z
dc.date.available2015-12-18T12:13:27Z
dc.date.issued1994-08
dc.identifier.citationEzeala,C.C. and Chukwurah, E. (1994) Hypothyroxinemia in Acquired Immune Deficiency Syndrome (AIDS), The Central African Journal of Medicine,(CAJM), vol. 40, no.8, pp.226-229. Harare: CAJM.en
dc.identifier.issn0008-9176
dc.identifier.urihttps://opendocs.ids.ac.uk/opendocs/handle/20.500.12413/7251
dc.descriptionA journal article on HIV/Aids.en
dc.description.abstractAcquired immune deficiency syndrome (AIDS), a disease predictive of a defect in the cell-mediated immunity, is caused by the human immuno-deficiency virus (HIV).1'1 Infection with this virus results in a gradual but progressive deterioration of immune function leading to disease manifestation. The syndrome is characterised by generalised infection and lymphad- enopathy, and is often associated with multisystem disorders. Patients with AIDS have been reported to have a high frequency of endocrine abnormalities, mostly affecting the adrenal gland, but also the thyroid and other endocrine organs.4-8 These lesions may result from necrosis, infection of the organs, or malignant transformations, presenting as Kaposi sarcomasen
dc.language.isoenen
dc.publisherFaculty of Medicine, Central African Journal of Medicine (CAJM), University of Zimbabwe (UZ)en
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/en
dc.subjectHIV/AIDSen
dc.titleHypothyroxinemia in Acquired Immune Deficiency Syndrome (AIDS)en
dc.typeArticleen
dc.rights.holderUniversity of Zimbabwe (UZ)en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-nd/3.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/3.0/